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UM4D4 is a recently defined antigen that is expressed on -25% of peripheral blood T cells, 
but on the majority of T cells in inflammatory synovial fluid. Anti-UM4D4 activates peripheral 
blood T cells in the presence of accessory cells and/or phorbol ester. UM4D4 has been assigned 
to a new antigen cluster termed CDw60. The present study examined the ability of anti-UM4D4 
to activate T cell clones derived from the synovial fluid of patients with rheumatoid arthritis. 
UM4D4 was expressed at varying levels on both lectin-generated and antigen-specific clones, 
including clones of CD4+, CD8+, and CD4-CD8- phenotypes. Anti-UM4D4 used in soluble 
form as a single stimulus was typically mitogenic for the CD4+ and some of the CD8+ clones, 
but not for the CD4-CD8- clones. Phorbol ester boosted the response to anti-UM4D4 in some 
clones, had no effect in others, and diminished the responses in some cases. In contrast to anti- 
UM4D4, anti-CD3 was generally not mitogenic in soluble form, although it was mitogenic when 
conjugated to beads. The data show that T cell clones derived from an inflammatory T cell 
infiltrate can be readily activated through the UM4D4/CDw60 antigen. o 1990 Academic PWSS, IX. 
INTRODUCTION 
T lymphocyte activation can be induced or augmented by stimulation of a variety 
of T cell surface structures distinct from the CD3-antigen receptor (CD3-TCR)3 com- 
plex ( 1- 14). Of these “alternative activation pathways,” the best characterized exam- 
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ple in man is CD2 ( I, 2), for which a natural ligand has been identified, cloned, and 
implicated as important for T cell development and activation in vivo ( 15- 17). 
Recently we have begun to characterize surface structures that may be important 
in T cell activation in autoimmune disease by generating monoclonal antibodies 
against T lymphocyte populations derived from the synovial compartment of pa- 
tients with rheumatoid arthritis (RA). One such antibody has been termed anti- 
UM4D4 and the surface antigen it binds to is designated UM4D4 (14). UM4D4 is 
expressed on a minority of peripheral blood T lymphocytes ( 14), but on the majority 
of T cells in inflammatory synovial fluid (18). Although UM4D4 expression is not 
augmented by T cell activation in vitro, T cell clones derived from high-UM4D4 
populations maintain expression of this antigen during long-term culture ( 14). Anti- 
UM4D4 is mitogenic for peripheral blood T cells in the presence of accessory cells 
and/or phorbol ester, and this response is inhibited by modulation of CD3/TCR ( 14). 
It appears, however, that UM4D4 is not closely associated structurally with CD3 
or other known T cell differentiation antigens (14). Immunoprecipitation with anti- 
UM4D4 identified a 92- to 94-kDa structure, following labeling with [35S]methionine 
(19), and a similar band, along with two bands at lower molecular weights, were 
obtained using Western blotting ( 14). 
Preliminary experiments indicated that anti-UM4D4 was directly mitogenic as a 
single stimulus for some, but not all, UM4D4+ T cell clones. The present series of 
experiments was therefore undertaken to more thoroughly characterize clonal T cell 
responses to stimulation through this newly identified activation pathway. 
MATERIALS AND METHODS 
T Cell Clones 
Two groups of T cell clones, both derived from RA synovial fluid T cells, were used 
in these studies. Forty lectin-stimulated clones were generated using PHA, feeder 
cells, and IL-2 containing medium as previously described (14, 20, 2 1). Southern 
blot analysis of TCR gene rearrangements was used to verify the clonality of these 
clones (2 1). 
A panel of antigen-specific clones used in these studies has also been previously 
described (22); these clones were reactive with the acetone-precipitable fraction of 
mycobacterium tuberculosis (AP-MT). 
Expression of surface markers (CD2, CD3, TCR, CD4, CD8, UM4D4) was mea- 
sured using indirect immunofluorescence and flow cytometry as previously described 
(14,22). 
Activation Assays 
These experiments were performed 11 to 14 days after the last previous restimula- 
tion of clones, at a time when ongoing proliferation was negligible. Fifty thousand 
cloned cells per well were plated in triplicate in 96-well round-bottom plates in RPM1 
1640 with 10% FCS. Stimuli in selected wells included anti-UM4D4 (generally at a 
1: 100 dilution of ascites), PMA (1 rig/ml), anti-CD3 (OKT3 ascites, l/100), or anti- 
CD3Sepharose. Anti-CD3-Sepharose was prepared as previously described (23). Af- 
ter 24 hr, 0.8 PCi [3H]TdR was added to each well, followed 18 hr later by harvesting 
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FIG. 1. Expression of UM4D4 (CDw60) on human T cell clones derived from RA synovial fluid, deter- 
mined by indirect immunofluorescene and flow cytometry using a Coulter Epics C instrument. Lectin- 
generated clones are indicated by closed circles and antigen-specific clones by open triangles. Each point 
denotes a separate clone, belonging to the phenotypic subset indicated on the x axis. 
of the cultures using a multichannel apparatus, Thymidine incorporation was then 
quantitated by liquid scintillation counting. 
RESULTS 
Expression of UM4D4 on T Cell Clones 
Two panels of human T cell clones derived from RA synovial fluid T cells were 
examined. All clones expressed CD2 and CD3. Of 40 lectin-generated clones, 27 were 
CD4+, 10 CD8+, and 3 CD4-CD8-. All of the lectin-generated clones were CD29+C- 
D45R-. Four of the five antigen-specific clones used in this study were CD4-CD8-, 
and these have been shown to express surface y6 TCR (22). The other antigen specific 
clone was CD4+ and it has also been described (22). 
Flow cytometric analysis revealed a broad range of UM4D4 expression on both 
the lectin-stimulated and antigen-specific clones (Fig. 1). Flow cytometry histograms 
of five representative CD4+ lectin-generated clones are shown in Fig. 2. Varying de- 
grees of UM4D4 expression were seen within each phenotypic group (CD4+, CD8+, 
and CD4-CD8-). Unlike antigens such as CD4 and CD8, many clones expressed 
UM4D4 at intermediate levels of fluorescence, with some cells below background 
intensity, and others strongly positive. This could not be explained by lack of clonality 
in the populations of cells studied, since monoclonality of all of these clones has been 
directly verified by Southern blot analysis of TCR gene rearrangements (2 1,22). The 
expression of UM4D4 on clones representing the different T cell subsets supports 
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FIG. 2. Flow cytometry histograms ofsurface antigens expressed by representative CD4+ lectin-generated 
clones. Histograms shown represent background fluorescence, CD3, CD4, and UM4D4. Clonality was 
verified by Southern blot analysis of TCR gene rearrangements (2 1). The % of cells expressing UM4D4 
was 8% for clone A, 50% for clone B, 45% for clone C, 85% for clone D. All clones were &TCR (WT3 l)- 
positive (data not shown). 
previous data indicating that UM4D4 defines a phenotypic T cell subset in peripheral 
blood distinct from populations identified by markers such as CD4 and CD8 ( 14). 
Activation of T Cell Clones by Anti- UM4D4 
Proliferative responses were measured following stimulation of each of the lectin- 
generated clones by anti-UM4D4. For most clones responses were also measured to 
soluble anti-CD3, and 10 clones were in addition examined for responses to immobi- 
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FIG. 3. Proliferative responses of lectin-generated T cell clones derived from RA synovial fluid to soluble 
anti-CD3, soluble anti-UM4D4, and Sepharose-conjugated anti-CD3. Results are expressed as the mean 
of triplicate cpm, and each point represents the response of an individual clone to the indicated stimulus. 
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TABLE 1 
Five Patterns of Clonal T Cell Proliferative Responses to Anti-UM4D4, 
Observed with Lectin-generated RA Synovial Fluid T Cell Clones 
Stimulation index (Mean f SEM) 
Group 0’) Anti-UM4D4 PMA Ani-UM4D4 + PMA 
I (6) 1.48 kO.21 1.44 + 0.09 1.44 + 0.27 
II (4) 2.19 k 0.36 1.80 + 0.30 23.60 -+ 13.90 
III (10) 28.66 f 7.47 2.89 XL 0.83 25.28 t- 5.58 
IV (9) 10.46 + 2.89 2.34 f 0.45 39.23 + 10.95 
V (11) 73.01 f 9.59 3.15 kO.73 25.16 + 4.49 
Note. The number of clones in each group is indicated in parentheses. Results are expressed as the mean 
stimulation index (cpm/background cpm) f SEM. The stimulation index for each individual clone was 
calculated from the mean of triplicate cpm. 
UM4D4 induced proliferative responses in most clones, varying in magnitude de- 
pending upon the clone tested. In contrast anti-CD3 was rarely mitogenic when used 
in soluble form, although consistently mitogenic when cross-linked to Sepharose. 
Similar results were obtained when proliferation was measured daily for 3 days fol- 
lowing stimulation of selected clones (data not shown). 
Heterogeneity of PMA Efects on Responses to Anti- UM4D4 
Since some clones did not respond to anti-UM4D4, experiments were done to 
determine whether inclusion of an additional costimulatory factor in the culture me- 
dium would lead to activation of these clones, and/or alter the responses of clones 
for which anti-UM4D4 alone was mitogenic. The phorbol ester PMA was used for 
this purpose at 1 rig/ml, a concentration at which PMA was minimally mitogenic for 
the clones as a single stimulus. For these experiments a proliferative response was 
defined as a stimulation index (cpm/background cpm) > 3, although most responses 
observed were much stronger. 
When the 40 lectin-generated clones were examined in this way, five patterns of 
responses were observed (Table 1). Clones in group I (6 clones) failed to respond to 
antiUM4D4, either alone or in the presence of PMA. The 4 clones in group II re- 
sponded to anti-UM4D4 only when PMA was also present. The majority of clones 
(30 of 40) responded to antiJJM4D4 alone and are contained in groups III, IV, and 
V. These latter three groups differed however, in the effect of PMA on the anti- 
UM4D4 response. In group III (10 clones) PMA had no effect on the magnitude of 
the response. In group IV (9 clones) PMA significantly boosted the response. For each 
clone in this group the response to PMA + anti-UM4D4 was at least 50% greater 
than the response to antiUM4D4 alone, and in general a several-fold increase was 
observed. The pattern observed in group V was of particular interest. The eleven 
clones in this group responded very well to antiUM4D4 alone and very slightly to 
PMA alone. In contrast to the other groups, PMA decreased the response of these 
clones to anti-UM4D4, generally to about one-third and always to < two-thirds of 
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TABLE 2 
Phenotype of T Cell Clones Belonging to Each Functional Group Delineated in Table 1 
Group 0’) CD4 pos CDS pos CD4CD8 neg 
% Pos UM4D4 
(mean + SD) 
I (6) 0 4 2 47231 
II (4) 3 0 I 51 +22 
III (10) 7 3 0 40+27 
IV (9) 8 1 0 45 f 27 
V (11) 9 2 0 50230 
Note. The number of clones in each group belonging to the phenotypic subsets defined by CD4 and CD8 
expression is indicated. UM4D4 expression is calculated as the mean f SD of the %UM4D4+ cells of all 
clones in a given group, using flow cytometric data. 
the response to anti-UM4D4 alone. When clones were repeatedly tested over a six- 
month period the same pattern of response was seen for a given clone. 
Phenotypic characteristics of clones in each group were examined to determine 
whether surface marker expression correlated with anti-UM4D4 responses. As shown 
in Table 2 a wide range of UM4D4 expression was found in each group, indicating 
that some clones with high UM4D4 expression did not respond to anti-UM4D4, and 
that some clones responded well despite relatively low expression of UM4D4. CD4+ 
clones all responded to anti-UM4D4 + PMA, and 24 of the 27 CD4+ clones re- 
sponded to anti-UM4D4 alone. Among CD8+ clones 6 of 10 responded to anti- 
UM4D4 alone but 4 showed no response to anti-UM4D4 or to anti-UM4D4 + PMA. 
None of the 3 CD4-CD8- clones responded to anti-UM4D4 alone, although one 
showed a weak response to anti-UM4D4 + PMA. 
The clones in group V were studied further because of the unexpected inhibitory 
effects of phorbol ester on the response to anti-UM4D4. This response pattern did 
not simply reflect a shift in the kinetics of proliferation in the presence of phorbol 
ester, since qualitatively similar results were obtained at multiple time points after 
initiation of the proliferation experiments (data not shown). Effects on the anti- 
UM4D4 response were seen over a range of concentrations of PMA from 0.1-10 ng/ 
ml, although less inhibition of the anti-UM4D4 response was observed at the lowest 
PMA concentration (Table 3). In addition a comparable decrease in the response to 
anti-CD3-Sepharose in the presence of PMA was observed in this group of clones, 
although PMA augmented the response to soluble anti-CD3 (Table 3). In contrast to 
the effects of PMA, costimulation with recombinant IL-2 did not reduce the response 
to anti-UM4D4 (data not shown). 
Eflects ofAnti-UM4D4 on Antigen-Specific Clones 
The activation experiments described above were done with lectin-generated 
clones. Additional experiments were performed to determine whether anti-UM4D4 
was also mitogenic for UM4D4+ clones generated and maintained by stimulation 
with a specific antigen, AP-MT. 
A representative TCR cr@ clone (Table 4) responded either to specific antigen or to 
anti-UM4D4. In contrast, two CD4-CD8- -yS clones, which also responded to spe- 
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TABLE 3 
Effect of PMA on Responses ofgroup V Clones to AntiWM4D4 and Anti-CD3 
PMA (rig/ml) 
Stimuli 0 0. I 0.5 1 5 10 
N0Ile 348+ 107 1116f 236 1447k 296 1498k 388 169Ok 571 1656k 495 
Anti-UM4D4 27149k6151 13423 f 2295 12004 f 2254 8151 + 1601 6493 + 1084 6951 f 1884 
Anti-CD3-Sepharose 35704 f 5623 N.D. N.D. 7259 + 1621 N.D. N.D. 
Anti-CD3 1913f 957 N.D. N.D. 6497 + 3175 N.D. N.D. 
Note. Four representative clones were studied. The results are expressed as the mean + SEM of the 
responses for all four clones. For each clone wells were set up in triplicate, and the mean cpm in each group 
was calculated. 
cific antigen, failed to respond to anti-UM4D4 (Table 4). One clone was tested with 
anti-UM4D4 + PMA, and showed only minimal proliferation to this combination 
of stimuli. All three clones responded to soluble anti-CD3 in the presence of added 
accessory cells. 
DISCUSSION 
In view of the strong expression of UM4D4/CDw60 on T cells found in certain 
compartmentalized autoimmune conditions, characterization of T cell activation 
through this structure is of particular interest. In this study T cell clones derived from 
RA synovial fluid were used since almost all of them express UM4D4, although at 
varying levels. The data indicate that a wide range of UM4D4 expression is found on 
clones within each of the phenotypic subsets defined by CD4 and CD8 (CD4+, CD8+, 
and CD4-CDS-). The lectin-stimulated CD4-CD8- clones, in contrast to the CD4+ 
and CD8+ clones, showed no staining with the WT3 1 monoclonal antibody directed 
against TCR c@ (data not shown). Although antibodies against TCR yS were not 
available during the period of viability of these clones, it is highly likely that these 
were TCR y6 clones. The TCR components of the antigen-specific clones used in 
TABLE 4 
Responses of AP-MT-Specific Clones to Stimulation by Antigen or by Anti-UM4D4 
Clone 
Stimuli 1.1(4 1.2 (74 1.4 (r@ 
None 882k 90 367+311 1209 + 175 
AP-MT 7563 + 307 4449k610 5633 + 294 
Anti-UM4D4 5459 + 757 175f 8 1493k 21 
Anti-UM4D4 + PMA N.D. 1431 + 278 N.D. 
Note. T cell clones were cultured in the presence of accessory cells as previously described (22). The TCR 
expressed by each clone is indicated in parentheses. Results are expressed as the mean i SEM of triplicate 
cpm. 
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these studies have been fully characterized (22), and it is therefore clear that UM4D4 
can be expressed on clones bearing TCR 76, as well as on clones bearing TCR cw/3. 
The mechanisms regulating the surface intensity of UM4D4 expression are not yet 
clear, but the current and previously published ( 14) data indicate that expression is 
heterogeneous on populations that are unequivocally clonal, to an extent not seen 
with conventional T cell subset markers such as CD4 and CD8. The fluorescence 
pattern observed for individual clones was generally stable on repeat testing over 
intervals of 2-6 months, in contrast to the instability of UM4D4 expression observed 
on malignant T cell lines ( 14, 19). 
The current experiments demonstrate that antiUM4D4 can potently activate T 
cell clones, even when used as a single stimulus, in the absence of additional factors 
such as accessory cells, IL-2, or phorbol ester. Feeder cells are no longer detectable in 
the clone cultures at the time interval after prior restimulation during which anti- 
UM4D4 responses were tested. The absence of accessory cells is supported by the 
general lack of response of the clones to soluble anti-CD3, in contrast to Sepharose- 
conjugated anti-CD3 which, as expected, was consistently mitogenic. The findings 
indicate that for T cell clones, the activation requirements for UM4D4 pathway trig- 
gering differ from the requirements for activation through the CD3-TCR complex. 
Anti-UM4D4 is an IgM antibody, in contrast to the IgG isotype of the mitogenic 
anti-CD3 antibody used in these studies. This discrepancy does not, however, explain 
the different effects on clonal proliferation, since a prototypic IgM anti-CD3 antibody 
is nonmitogenic and inhibits various T cell responses ( 14,24,25). 
The effects of anti-UM4D4 are similar to responses observed in murine cells with 
antibodies directed against the Thy-l and TAP antigens (9, 12), but available bio- 
chemical information about UM4D4 ( 14, 19) does not suggest any similarity to Thy- 
1 or TAP. 
It should be noted that in contrast to clones, peripheral blood T cells cannot be 
activated by anti-UM4D4 in the absence of accessory cells unless a second stimulus, 
such as PMA, is added ( 14). Even in the presence of monocytes, responses may be 
suboptimal without PMA (14). These findings imply that prior activation of T cells 
could render them more susceptible to activation by anti-UM4D4, even though 
UM4D4 expression does not appear to increase as a consequence of T cell activa- 
tion ( 14). 
Interesting heterogeneity was observed in the clonal responses to anti-UM4D4. 
Some clones did not proliferate in the presence of anti-UM4D4, although costimula- 
tion with anti-UM4D4 + phorbol ester induced proliferation in 6 of 10 of these clones 
(group II). Lack of response could not be explained by lower expression of UM4D4. 
Interestingly, all of the CD4-CD8- clones tested either failed to respond to anti- 
UM4D4 under any circumstances, or else showed a very minimal response in the 
presence of PMA. 
Striking heterogeneity was also observed in the clones that did respond to anti- 
UM4D4, with phorbol ester reproducibly either increasing, not affecting, or lowering 
the response of a given clone. In group V, in which inhibitory effects of PMA were 
observed, a similar inhibition of responses to anti-CD3Sepharose was also seen. This 
could not be explained simply by toxic effects of PMA on these clones since, the 
number and viability of cells was not reduced, the effects were observed at PMA 
concentrations as low as 0.1 rig/ml, and the response to soluble anti-CD3 was en- 
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hanced rather than lowered. The findings imply that under certain circumstances 
activation (or perhaps excessive activation) of protein kinase C in T cell clones can 
exert growth-inhibitory rather than stimulator-y effects. Similar inferences have been 
drawn from observations of phorbol ester effects in other systems (26). Possible effects 
of PMA other than activation of protein kinase C are, however, difficult to exclude. 
It is also of interest that activation of protein kinase C in a murine T cell line by 
diacyglycerol analogs, but not PMA, was found to limit cell activation and IL-2 pro- 
duction (27). 
The results of these studies raise questions about the signaling mechanisms em- 
ployed by the UM4D4 activation pathway, and suggest that heterogeneity in signaling 
might be found in different clones, or in clones compared to peripheral blood T cells. 
Preliminary findings (Fox, D. A., Davis, W., June, C., unpublished observations) 
indicate that peripheral blood T cells can proliferate in response to anti-UM4D4 in 
the absence of a detectable increase in cytoplasmic free calcium. Further analysis 
of several potential signaling mechanisms will therefore be required to resolve these 
issues. 
The results obtained using clones specific for the AP-MT antigen indicate that re- 
petitive stimulation with antigen is compatible with continued expression of 
UM4D4, and in certain cases with retention of the capacity to be activated through 
UM4D4. This suggests that, if a ligand of UM4D4 were present in autoimmune le- 
sions such as RA synovial tissue, the UM4D4 pathway could contribute to maintain- 
ing activation of T cells that had initially responded to specific antigen. 
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